Nomura Holdings’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Nomura Holdings’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,850	Closed	-$54K	–	1771
2016 Q1	$54K	Buy	+2,850	New	+$54.8K	﹤0.01%	1449
2015 Q3	–	Sell	-2,703	Closed	-$87K	–	2101
2015 Q2	$87K	Buy	+2,703	New	+$78.5K	﹤0.01%	1683
2014 Q4	–	Sell	-231,553	Closed	-$6.25M	–	2903
2014 Q3	$6.25M	Buy	231,553 +4,875	+2%	+$129K	0.02%	608
2014 Q2	$6.71M	Sell	226,678 -325	-0.1%	-$10.5K	﹤0.01%	552
2014 Q1	$8.4M	Buy	227,003 +35,444	+19%	+$1.34M	﹤0.01%	539
2013 Q4	$7.95M	Buy	191,559 +34,780	+22%	+$1.36M	0.04%	277
2013 Q3	$8.3M	Buy	156,779 +69,976	+81%	+$4.08M	0.05%	305
2013 Q2	$4.6M	Buy	+86,803	New	+$4.33M	0.04%	344

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Holdings's NAVB Position: Q2 2016 in Review

Nomura Holdings sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2016, closing a stake of 2,850 shares — an estimated $54K sold.

Nomura Holdings first reported a position in NAVB in Q2 2013 and held it in 8 quarters. The position peaked at $8.4M in Q1 2014. 63 funds tracked by Wall St. Rank hold NAVB as of Q2 2016.

Nomura Holdings reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
Nomura Holdings sold 2,850 Navidea Biopharmaceuticals Inc. shares in Q2 2016, an estimated $54K.
Nomura Holdings first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 8 quarters.
Nomura Holdings's Navidea Biopharmaceuticals Inc. position peaked at $8.4M in Q1 2014.
63 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.